| Abstract | The Authors have done a clinical study on the efficacy of desmopressin (DDAVP) tablets in the treatment of central diabetes insipidus in 13 patients who were previously treated with intranasal DDAVP. A comparison has been made between peroral and intranasal forms of DDAVP measuring the urinary volume and osmolarity daily. The right dosage of DDAVP tablets was between 150 and 600 micrograms/die. The patients showed very good compliance during the 4 weeks of treatment with DDAVP. |
| Authors | A Carraro, M Fano, E Porcella, V Bernareggi, M Giusti
(Affiliation: Cattedra di Endocrinologia, Università di Genova.)
|
| Journal | Minerva endocrinologica
(Minerva Endocrinol)
1991 Jul-Sep
Vol. 16
Issue 3
Pg. 141-5
ISSN: 0391-1977 ITALY |
| Vernacular Title | Trattamento del diabete insipido centrale con DDAVP per via orale. Confronto con il trattamento per via endonasale. |
| PMID | 1806811
(Publication Type: Clinical Trial, Comparative Study, Controlled Clinical Trial, English Abstract, Journal Article)
|
| Chemical References |
- Deamino Arginine Vasopressin
|
| Topics |
- Administration, Intranasal
- Administration, Oral
- Adolescent
- Adult
- Deamino Arginine Vasopressin
(administration & dosage, pharmacology, therapeutic use)
- Diabetes Insipidus
(drug therapy, urine)
- Diuresis
(drug effects)
- Drug Evaluation
- Female
- Humans
- Male
- Middle Aged
- Osmolar Concentration
- Patient Acceptance of Health Care
|
